TOKYO -- Japanese biotechnology company PrimRNA will launch clinical trials for a treatment using messenger RNA to repair osteoarthritis of the knee, a condition that afflicts many older adults.
Biotechnology
Japanese biotech firm to test mRNA treatment for knee arthritis
Phase 1 trials to start as soon as September with aim to market shot in the 2030s
The work done by University of Osaka professor Keiji Itaka and his research team led to the clinical trials. (Photo provided by Keiji Itaka)
Read Next
Latest on Biotechnology
